東軟載波(300183.SZ):擬參與競買昂立生命100%股權
格隆匯 11 月 17日丨東軟載波(300183.SZ)公佈,公司的全資子公司上海東軟載波微電子有限公司擬參與競買上海交大昂立生命科技發展有限公司100%股權,上海交大昂立生命科技發展有限公司已在上海聯合產權交易所公開掛牌,轉讓底價為人民幣5380.94萬元。
上海微電子現有經營辦公場地通過租賃取得且已無法滿足日常經營管理使用。為匹配公司後續業務規模,亟需增加研發和經營辦公場地。本次競買昂立生命100%股權,主要着眼於昂立生命位於上海市徐彙區田州路99號的自有房產。此次交易完成後,昂立生命將成為上海微電子的全資子公司,上海微電子擬利用昂立生命所擁有的房屋作為公司新的辦公場地和研發中心,將極大改善辦公環境,提高公司整體形象,更好地吸引優秀人才,提升研發能力,為公司在上海的業務發展奠定牢固的基礎,進一步整合資源和完善公司資源配置,符合公司長遠發展規劃及全體股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.